GlassScriptPhysician profile
Christopher G Baalmann
NPI 1992099113
$4,795.57
in general payments reported to CMS, 2019-2025
19 companies · $234 in 2025
The $234 reported for 2025 was less than what a typical Vascular & Interventional Radiology provider received nationally (typical 2025 total: $537).
See the full distribution for Vascular & Interventional Radiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,381 · 2020: $288 · 2021: $644 · 2022: $1,047 · 2023: $518 · 2024: $683 · 2025: $234.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,435.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,435.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $790.55 | 2019-2025 | Flowtriever |
| Inari Medical, INC. | $702.77 | 2021-2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Angiodynamics, INC. | $662.14 | 2020-2024 | Alphavac, Nanoknife, Solero |
| Boston Scientific Corporation | $604.29 | 2019-2023 | |
| Abbott Laboratories | $386.08 | 2022-2024 | Esprit, Jeti Peripheral Catheter, Perclose Prostyle |
| Medtronic, INC. | $365.27 | 2021-2025 | Abre, Emprint |
| Shockwave Medical, INC | $285.88 | 2021-2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Astrazeneca Pharmaceuticals LP | $249.98 | 2023-2024 | Imfinzi |
| Medtronic Vascular, INC. | $145.02 | 2019-2020 | |
| Microvention, INC. | $144.15 | 2019 | |
| Eisai INC. | $121.90 | 2022 | |
| Philips North America LLC | $87.12 | 2019-2020 | |
| Bard Peripheral Vascular, INC. | $75.98 | 2024-2025 | Venovo, Covera |
| Trisalus Life Sciences, INC. | $41.49 | 2022 | |
| Medtronic USA, INC. | $39.35 | 2019 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dendreon Pharmaceuticals LLC | $28.77 | 2025 | Provenge |
| Siemens Medical Solutions USA, INC. | $27.52 | 2025 | Embozene |
| Sirtex Medical INC | $19.97 | 2019 | |
| Janssen Biotech, INC. | $17.34 | 2025 | Erleada |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Baalmann listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.